Answers are grounded in this paper and cite their sources.
SAR of N-alkylated isoxazolones as p38 MAP kinase inhibitors was realized. The data herein show the possibility of transferring the SAR study and evaluation from N-1-substituted imidazole to isoxazolones. Optimization of substituent was realized.
No takes yet. Share an insight, caveat, or question.
Laufer et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: